logo
Plus   Neg
Share
Email

PDL BioPharma Inc. Q3 adjusted earnings of -$ per share

Below are the earnings highlights for PDL BioPharma Inc. (PDLI):

-Earnings: -$17.78 million in Q3 vs. $25.56 million in the same period last year.
-EPS: -$0.16 in Q3 vs. $0.18 in the same period last year.
-Revenue: $44.17 million in Q3 vs. $67.90 million in the same period last year.

-Guidance:
Full year revenue guidance: $50 - $55 Mln

For comments and feedback contact: editorial@rttnews.com

RELATED NEWS
Follow RTT
>